نتایج جستجو برای: acellular vaccine

تعداد نتایج: 111761  

Journal: :Pediatrics 2012
James D Cherry

The first reason, and perhaps the most important one, is that our estimates of vaccine efficacy have been inflated because of case definition.3–11 At the time of the pediatric diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine efficacy trials in the early 1990s, it was hoped that a universal case definition could be developed so that the results of the various trials could be...

Journal: :Japanese journal of infectious diseases 2001
Y Horiuchi M Takahashi T Konda M Ochiai A Yamamoto M Kataoka H Toyoizumi Y Arakawa

Diphtheria tetanus acellular pertussis combined (DTaP) vaccines have been successfully used in Japan by controlling their potencies and toxicities with animal models. In accordance with the recent practical introduction of DTaP vaccines of various formulations, a question has been raised in other nations as to the efficacy of a quality control system based on animal tests and standard preparati...

2018
Geert Leroux-Roels Maria Lattanzi Claudia Dovali Solis Mario Contorni Marco Costantini Luca Moraschini Monia Bardelli Sylvie Bertholet Erica Borgogni Francesca Buricchi Rocco Cantisani Elisa Faenzi Oretta Finco Rosanna Leuzzi Mariagrazia Pizza Domenico Rosa Francesca Schiavetti Anja Seubert Fabiana Spensieri Gianfranco Volpini Luisanna Zedda Giuseppe Del Giudice Ilaria Galgani

Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries. This randomized, controlled, observer-blind phase I study and extension study in Belgium (March 2012-June 2015) assessed safety and immunogenicity of investigational acellular pertussis vaccines containing genetically detoxified pertussis toxin (PT) (NCT01529645; NCT02382913). 420 healthy adults (average ag...

Journal: :The Journal of Allergy and Clinical Immunology: In Practice 2021

Background An Australian study including 4433 children found that delayed Diphtheria-Tetanus-acellular Pertussis–containing vaccination was associated with reduced risk of developing atopic dermatitis (AD) before age 1 year. Objective We assessed whether against diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b (Diphtheria, Tetanus, Pertussis – Inactivated Polio...

Journal: :Infection and immunity 2005
Julie Rowe Stephanie T Yerkovich Peter Richmond Devinda Suriyaarachchi Elizabeth Fisher Leonie Feddema Richard Loh Peter D Sly Patrick G Holt

Acellular vaccines against diphtheria-tetanus-pertussis (acellular pertussis) (DTaP) are being progressively introduced into vaccination programs worldwide, with the aim of reducing T-helper 1 (Th1)-associated reactogenicity associated with the cellular diphtheria-tetanus-pertussis (whole-cell pertussis) (DTwP) vaccine. The DTaP vaccine has an improved safety profile in infants, but little info...

Journal: :P & T : a peer-reviewed journal for formulary management 2016
Juan F Mosley Lillian L Smith Crystal K Parke Jamal A Brown Justin M LaFrance Patricia K Clark

INTRODUCTION Vaccinations in school-aged children are required by state and local law to maintain high vaccination coverage rates, as well as low rates of vaccine-preventable diseases. Diphtheria, tetanus, and pertussis are childhood diseases that can be life threatening; poliomyelitis, another childhood disease, can be disabling. In turn, vaccinations were developed to provide protection again...

Journal: :MMWR. Morbidity and mortality weekly report 2009

On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) Boostrix (GlaxoSmithKline Biologicals, Rixensart, Belgium). Boostrix is now licensed for use in persons aged 10-64 years as a single-dose booster immunization; the vaccine initially was licensed for persons aged ...

Journal: :The Journal of infectious diseases 1996
H J Schmitt A Schuind M Knuf F Zepp K Beutel C H Wirsing von König A Neiss H L Bock H Bogaerts R Clemens

After concern about the safety of diphtheria-tetanus toxoid-whole cell pertussis vaccines (DTPw), the recommendation to vaccinate children with DTPw was withdrawn in 1974 in the former West Germany. This led pertussis cases to increase to an estimated 100,000 annually. Despite renewal of the vaccination recommendation in 1991, vaccine use remained low. The German health care structure assures r...

2015
Megumi Hara Mami Fukuoka Katsuya Tashiro Iwata Ozaki Satoko Ohfuji Kenji Okada Takashi Nakano Wakaba Fukushima Yoshio Hirota

BACKGROUND Recent studies worldwide have reported increasing numbers of adults diagnosed with Bordetella pertussis despite receiving childhood vaccinations. This study describes a pertussis outbreak at a university medical faculty campus and examines the effectiveness of diphtheria, tetanus, and pertussis (DTaP) vaccination completed during infancy in Japan. METHODS After the outbreak, self-a...

Journal: :British medical bulletin 2002
Myron M Levine James D Campbell Karen L Kotloff

During the past two decades, advances in biotechnology and increased knowledge of the inductive and effector components of immune responses have revolutionized the field of vaccine development. This has opened a vaccine ‘pipeline’ that has already resulted in the licensure of many new and improved vaccines including recombinant hepatitis B vaccine, acellular pertussis vaccines, and conjugate va...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید